# ET 50 for Post Caesarean Section Spinal Hypotension

> **NCT01561274** · PHASE2 · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 50 (actual)

## Conditions studied

- Hypotension

## Interventions

- **DRUG:** 2 ml bupivacaine
- **DRUG:** 1.5 ml bupivicaine.

## Key facts

- **NCT ID:** NCT01561274
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2014-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561274, "ET 50 for Post Caesarean Section Spinal Hypotension". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01561274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*